A 14-day repeat dose oral gavage range-finding study of a first-in-class CDI investigational antibiotic, in rats
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Boulos, Ramiz A.
Text and Data Mining valid from 2019-01-17
1 June 2018
26 November 2018
17 January 2019
R.A.B. is an employee, Board Member and shareholder of Boulos & Cooper Pharmaceuticals.